RITUXIMAB MAINTENANCE AFTER NORDIC PROTOCOL (R-MAXICHOP/HD-ARAC/ASCT) SIGNIFICANTLY PROLONGS SURVIVAL IN YOUNG MANTLE CELL LYMPHOMA PATIENTS
Klener, P., Salek, D., Mocikova, H., Blahovcova, P., Pytlik, R., Janikova, A., Prochazka, V., Campr, V., Boudova, L., Jaksa, R., Kodet, R., Trneny, M.Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2438_70
Date:
June, 2017
File:
PDF, 173 KB
english, 2017